Ifitm3 limits the severity of acute influenza in mice

Charles C Bailey1, I-Chueh Huang, Christina Kam

  • 1Department of Microbiology and Immunobiology, Harvard Medical School, New England Primate Research Center, Southborough, Massachusetts, United States of America. charles_bailey@hms.harvard.edu

Plos Pathogens
|September 13, 2012
PubMed

Insights

Interferon-induced transmembrane protein 3 (IFITM3) is crucial for limiting influenza A virus infection in mice. Its absence accelerates disease, increases mortality, and elevates viral loads, highlighting its vital role in host defense.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Interferon-induced transmembrane (IFITM) proteins restrict viral entry in vitro.
  • Influenza A virus (IAV) poses a significant global health threat.

Purpose of the Study:

  • To investigate the in vivo role of IFITM proteins, particularly IFITM3, in influenza A virus infection.
  • To elucidate the expression and regulation of IFITM3 during viral infection.

Main Methods:

  • Utilized knockout mouse models lacking the Ifitm locus or specifically Ifitm3.
  • Assessed disease progression, mortality, and viral burdens post-IAV infection.
  • Examined Ifitm3 expression in respiratory tissues and its regulation by interferons and cytokines.

Main Results:

  • Mice lacking the Ifitm locus or Ifitm3 showed accelerated IAV disease, higher mortality, and increased viral loads.
  • Ifitm3 is expressed in key IAV target cells (alveolar type II pneumocytes, respiratory epithelial cells).
  • Ifitm3 expression is induced by type I/II interferons and gp130 cytokines (IL-6, oncostatin M).

Conclusions:

  • IFITM3 plays a central role in limiting acute influenza A virus infection in vivo.
  • Multiple cytokine signals contribute to cell/tissue-specific Ifitm3 expression.
  • Understanding IFITM3 regulation offers insights into host antiviral defense mechanisms.

Related Concept Videos